Articles
Volume 10 Supplement 4
Annual Conference on Hereditary Cancers 2012
Meeting abstracts
Annual Conference on Hereditary Cancers 2012
Szczecin, Poland
30-31 August 2012
Edited by Jan Lubiński
Publication of this supplement has been funded by the Polish Ministry of Science and Higher Education.
|
Selenium and cancer prevention Margaret Rayman Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A1 (10 December 2012) |
|
Microelements as risk factors for cancer of the lung and larynx Katrzyna Jaworska-Bieniek, Satish Gupta, Katarzyna Durda, Magdalena Muszynska, Grzegorz Sukiennicki, Elżbieta Jaworowska, Tomasz Grodzki, Mieczysław Sulikowski, Piotr Woloszczyk, Janusz Wójcik, Jakub Lubiński, Cezary Cybulski, Tadeusz Dębniak, Marcin Lener, Steven A Narod, Ping Sun, Jan Lubiński, Anna Jakubowska Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A2 (10 December 2012) |
|
Selenium and gastrointestinal cancers risk Marcin Lener, Anna Jakubowska, Anna Wiechowska-Kozłowska, Józef Kładny, Magdalena Muszyńska, Grzegorz Sukiennicki, Jan Lubiński Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A3 (10 December 2012) |
|
Selenium (Se) and breast cancer risk Katarzyna Jaworska - Bieniek, Anna Jakubowska, Katarzyna Durda, Tomasz Huzarski, Pablo Serrano-Fernandez, Grzegorz Sukiennicki, Magdalena Muszyńska, Tomasz Byrski, Jacek Gronwald, Satish Gupta, Katarzyna Kaczmarek, Jan Lubiński Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A4 (10 December 2012) |
|
Grzegorz Sukiennicki, Magdalena Muszyńska, Tomasz Huzarski, Jacek Gronwald, Cezary Cybulski, Tadeusz Dębniak, Aleksandra Tołoczko-Grabarek, Oleg Oszurek, Anna Jakubowska, Antoni Morawski, Jan Lubiński Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A5 (10 December 2012) |
|
Katarzyna Kaczmarek, Anna Jakubowska, Grzegorz Sukiennicki, Magdalena Muszyńska, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Tomasz Huzarski, Pablo Serrano-Fernandez, Tomasz Byrski, Jacek Gronwald, Satish Gupta, Jan Lubiński Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A6 (10 December 2012) |
|
Folic acid and breast cancer risk Katarzyna Durda, Katrzyna Jaworska-Bieniek, Krzysztof Kąklewski, Jan Lubiński, Anna Jakubowska Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A7 (10 December 2012) |
|
Arsenic (As) and breast cancer risk Magdalena Muszyńska, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Grzegorz Sukiennicki, Tomasz Gromowski, Anna Jakubowska, Antoni Morawski, Jan Lubiński Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A8 (10 December 2012) |
|
Ramunas Janavicius Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A9 (10 December 2012) |
|
Cancer predisposing BARD1 mutations in breast-ovarian cancer families Magdalena Ratajska, Magdalena Matusiak, Izabela Brożek, Maciej Stukan, Marcin Śniadecki, Jarosław Dębniak, Dariusz Wydra, Janusz Limon Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A10 (10 December 2012) |
|
Paweł Boruń, Andrzej Plawski, Anna Bartkowiak, Wojciech Cichy Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A11 (10 December 2012) |
|
Male breast cancer in the prophylactics programme by the Ministry of Health of Poland Artur Barczyk Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A12 (10 December 2012) |
|
Satish Gupta, Katarzyna Jaworska, Anna Jakubowska, Tomasz K Wojdacz, Lise Hansen, Jan Lubiński Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A13 (10 December 2012) |
|
GWAS markers in diagnostics of breast cancer risk Anna Jakubowska Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A14 (10 December 2012) |
|
BRCA1 mutation in the Triple- Negative Breast Cancer Group Jelena Maksimenko, Arvids Irmejs, Genadijs Trofimovics, Edvins Miklasevics Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A15 (10 December 2012) |
|
Systemic therapy for hereditary cancer Evgeny N Imyanitov Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A16 (10 December 2012) |
|
Cisplatin in breast cancer treatment in BRCA1 carriers Jacek Gronwald, Tomasz Byrski, Jan Lubinski, Steven A Narod Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A17 (10 December 2012) |
|
Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer T T Huzarski, B Górecka-Szyld, J J Huzarska, G Psut, G Wilk, R Sibilski, C Cybulski, B Kozak-Klonowska, M Siołek, E Kilar, D Czudowska, H Janiszewska, D Godlewski, A Mackiewicz, J Jarkiewicz-Tretyn, I Szabo-Moskal, J Gronwald, J Lubiński, SA Narod, Polish Hereditary Breast Cancer Study Group Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A18 (10 December 2012) |
|
Impact of BRCA1 mutation on survival after early onset breast cancer T Huzarski, T Byrski, J Gronwald, B Górski, W Domagała, C Cybulski, Ping Sun, O Oszurek, M Szwiec, K Gugała, M Stawicka, Z Morawiec, T Mierzwa, H Janiszewska, E Kilar, E Marczyk, B Kozak-Klonowska, M Siołek, D Surdyka, R Wiśniowski, M Posmyk, J Lubiński, SA Narod, Polish Breast Cancer Consortium Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A19 (10 December 2012) |
|
The prevalence of CHEK2 and CYP1B1 mutations/polymorphisms in urinary bladder cancer Monika Banaszkiewicz, Maria Constantinou, Michał Pietrusiński, Łukasz Kępczyński, Adam Jędrzejczyk, Marek Rożniecki, Piotr Marks, Bogdan Kałużewski Hereditary Cancer in Clinical Practice 2012, 10(Suppl 4):A20 (10 December 2012) |

